Skip to main content
Tech.euFundingExplorerBeta

MRM Health

Ghent-based clinical-stage biopharmaceutical company developing microbiome-based therapeutics for inflammatory diseases and immune-oncology

MRM Health has raised €55M across 1 funding round from 8 investors, most recently a Series B round in Sep 2025. Based in Ghent, Belgium; active in Healthtech. Data as of 28 Oct 2026.

Ghent, Belgiummrmhealth.com ↗
Healthtech
← All companies
Total raised
€55M
€55,000,000
Funding rounds
1
Investors
8
distinct backers
Active since
2025-09
latest 2025-09

Funding by year

EUR raised per year
MRM Health — funding by year — interactive chart.
Data table
MRM Health — funding by year
2025€55M

Signals

High confidence
Raise-next likelihood65
base rate 48% for Series B
  • ▲ In typical raise window
  • ▼ Low backer re-investment

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2025-09-04Series B€55MAckermans & van Haaren (AvH),Athos Capital,Biocodex,BNP Paribas Fortis Private Equity,OMX Europe Venture Fund (OMX),Qbic II+2 moreView deal →

Investors

8
Ackermans & van Haaren (AvH)Athos CapitalBiocodexBNP Paribas Fortis Private EquityOMX Europe Venture Fund (OMX)Qbic IISFPIMVIB

Related news

Similar companies

same sector or country

Global coverage: FundingData